Our data propose a fundamental clinical tumor suppressive role of NDRG2 in hormone-receptor positive breast cancer while in basal-like breast cancer patient’s abundant NDRG2 expression is associated with unfavorable patients’ outcome and a more aggressive phenotype in vitro. The gene discussed is NDRG2; the disease is breast carcinoma.